Skip to main content
Premium Trial:

Request an Annual Quote

TATAA Biocenter to Distribute TriLink Real-Time PCR Reagents


TriLink Biotechnologies said today that it has entered into a distribution agreement with TATAA Biocenter to sell TriLink's CleanAmp products.

TATAA, headquartered in Gothenburg, Sweden, develops and performs a broad spectrum of hands-on qPCR courses worldwide and provides tailor-made products for real-time PCR applications.

TriLink's CleanAmp product line uses an innovative approach to hot start PCR that helps resolve common PCR problems, such as primer-dimer formation and mispriming.

TriLink said that the latest addition to the product line, improved CleanAmp dNTPs, will be available next month. This new product enables improved amplicon yield in endpoint PCR and earlier Cq values in fast-cycling real-time PCR, the company said.

"The CleanAmp hot-start technique … is so much more versatile and easy to implement compared to alternatives, and being supported by our application specialists we expect it will become a most popular product," Mikael Kubista, founder and CEO of TATAA Biocenter, said in a statement.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.